Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Hester, van Cruijsen"'
Autor:
Patricia A.H. Hamers, Geraldine R. Vink, Marloes A.G. Elferink, Rebecca K. Stellato, Willemieke P.M. Dijksterhuis, Cornelis J.A. Punt, Miriam Koopman, Anne M. May, Laurens V. Beerepoot, Geert-Jan Creemers, Hester van Cruijsen, Jan Willem B. de Groot, Henk K. van Halteren, Helgi H. Helgason, Mathijs P. Hendriks, Ronald Hoekstra, Lieke H. van Huis-Tanja, Ellen Kapiteijn, Maartje Los, Esther van Meerten, Natascha A.J.B. Peters, Johannes F.M. Pruijt, Patricia Quarles van Ufford-Mannesse, Mark P.S. Sie, Dirkje W. Sommeijer, Leontine E.A.M.M. Spierings, Frederiek Terheggen, Manuel L.R. Tjin-A-Ton, Liselot B.J. Valkenburg-van Iersel, Theo van Voorthuizen, Judith de Vos-Geelen, Annelie J.E. Vulink, Agnès J van de Wouw
Publikováno v:
Clinical Colorectal Cancer, 21(2), 154-166. Elsevier
on behalf of the QUALITAS study group 2022, ' Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS) ', Clinical Colorectal Cancer, vol. 21, no. 2, pp. 154-166 . https://doi.org/10.1016/j.clcc.2022.03.002
Clinical colorectal cancer, 21(2), 154-166. Elsevier
Clinical Colorectal Cancer, 21(2), 154-166. CIG Media Group, L.P.
on behalf of the QUALITAS study group 2022, ' Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS) ', Clinical Colorectal Cancer, vol. 21, no. 2, pp. 154-166 . https://doi.org/10.1016/j.clcc.2022.03.002
Clinical colorectal cancer, 21(2), 154-166. Elsevier
Clinical Colorectal Cancer, 21(2), 154-166. CIG Media Group, L.P.
INTRODUCTION: The RECOURSE trial demonstrated a modest benefit in overall survival (OS) for trifluridine/tipiracil (FTD/TPI) versus placebo in pretreated metastatic colorectal cancer (mCRC) patients. Unfortunately, quality of life (QoL) was not asses
Autor:
Tanja D. de Gruijl, Klaas Hoekman, Epie Boven, Alfons J.M. van den Eertwegh, John B.A.G. Haanen, Giuseppe Giaccone, Rik J. Scheper, Henk J. Broxterman, Dinja Oosterhoff, Laura Vroling, Astrid A.M. van der Veldt, Hester van Cruijsen
Purpose: A disturbed myeloid lineage development with abnormally abundant neutrophils and impaired dendritic cell (DC) differentiation may contribute to tumor immune escape. We investigated the effect of sunitinib, a tyrosine kinase inhibitor of fms-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ef92c47b977047796352d26cc5cfcae
https://doi.org/10.1158/1078-0432.c.6517093.v1
https://doi.org/10.1158/1078-0432.c.6517093.v1
Autor:
Tanja D. de Gruijl, Klaas Hoekman, Epie Boven, Alfons J.M. van den Eertwegh, John B.A.G. Haanen, Giuseppe Giaccone, Rik J. Scheper, Henk J. Broxterman, Dinja Oosterhoff, Laura Vroling, Astrid A.M. van der Veldt, Hester van Cruijsen
Supplementary Figure S1 from Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59fcce9cdc8912e0795097d1b4ab98bf
https://doi.org/10.1158/1078-0432.22439656.v1
https://doi.org/10.1158/1078-0432.22439656.v1
Autor:
Karel C, Smit, Jeroen W G, Derksen, Geerard L O, Beets, Eric J Th, Belt, Maaike, Berbée, Peter Paul L O, Coene, Hester, van Cruijsen, Marjan A, Davidis, Jan Willem T, Dekker, Joyce M, van Dodewaard-de Jong, Annebeth W, Haringhuizen, Helgi H, Helgason, Mathijs P, Hendriks, Ronald, Hoekstra, Ignace H J T, de Hingh, Jan N M, IJzermans, Johan J B, Janssen, Joop L M, Konsten, Maartje, Los, Leonie J M, Mekenkamp, Peter, Nieboer, Koen C M J, Peeters, Natascha A J B, Peters, Hans J F M, Pruijt, Patricia, Quarles van Ufford-Mannesse, Ron C, Rietbroek, Anandi H W, Schiphorst, Arjan, Schouten van der Velden, Ruud W M, Schrauwen, Mark P S, Sie, Dirkje W, Sommeijer, Dirk J A, Sonneveld, Hein B A C, Stockmann, Marleen, Tent, Frederiek, Terheggen, Manuel L R, Tjin-A-Ton, Liselot, Valkenburg-van Iersel, Ankie M T, van der Velden, Wouter J, Vles, Theo, van Voorthuizen, Johannes A, Wegdam, Johannes H W, de Wilt, Miriam, Koopman, Anne M, May, On Behalf Of The Plcrc Study Group
Publikováno v:
Cancers; Volume 14; Issue 4; Pages: 1001
Cancers, 14(4):1001. Multidisciplinary Digital Publishing Institute (MDPI)
PLCRC study group 2022, ' Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer ', Cancers, vol. 14, no. 4, 1001 . https://doi.org/10.3390/cancers14041001
Cancers, 14
Cancers, 14, 4
Cancers, 14(4):1001. Multidisciplinary Digital Publishing Institute (MDPI)
PLCRC study group 2022, ' Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer ', Cancers, vol. 14, no. 4, 1001 . https://doi.org/10.3390/cancers14041001
Cancers, 14
Cancers, 14, 4
Regular physical activity (PA) is associated with improved overall survival (OS) in stage I–III colorectal cancer (CRC) patients. This association is less defined in patients with metastatic CRC (mCRC). We therefore conducted a study in mCRC patien
Autor:
Seyed M. Qaderi, Joost A.G. van der Heijden, Rob H.A. Verhoeven, Johannes H.W. de Wilt, Jose A.E. Custers, Geerard L. Beets, Eric J.Th. Belt, Maaike Berbée, Frederique H. Beverdam, Ruud Blankenburgh, Peter Paul L.O. Coene, Jan Willem B. de Groot, Ignace H.J.T. de Hingh, Aad I. de Vos, Jan Willem T. Dekker, Frans L.G. Erdkamp, Annebeth W. Haringhuizen, Helgi H. Helgason, Mathijs P. Hendriks, Ronald Hoekstra, Jan N.M. Ijzermans, Jan Jansen, Frank W.H. Kloppenberg, Maartje Los, Martijn R. Meijerink, Leonie J.M. Mekenkamp, Peter Nieboer, Koen C.M.J. Peeters, Natascha A.J.B. Peters, Marco B. Polée, Johannes F.M. Pruijt, Patricia Quarles van Ufford-Mannesse, Ron C. Rietbroek, Anandi H.W. Schiphorst, Arjan Schouten van der Velden, Ruud W.M. Schrauwen, Mark P.S. Sie, Lieke Simkens, Dirkje W. Sommeijer, Dirk J.A. Sonneveld, Leontine E.A. Spierings, Hein B.A.C. Stockmann, Koen Talsma, Albert J. ten Tije, Frederiek Terheggen, Manuel L.R. Tjin-A-Ton, Liselot B.J. Valkenburg-van Iersel, Hester van Cruijsen, Ankie M.T. van der Velden, Joyce M. van Dodewaard-de Jong, Anja U.G. van Lent, Theo van Voorthuizen, Maarten Vermaas, Wouter J. Vles, Jeroen F.J. Vogelaar, David D.E. Zimmerman
Publikováno v:
European Journal of Cancer, 158, 144-155. Elsevier Limited
European Journal of Cancer, 158, 144-155. Pergamon
European Journal of Cancer, 158, 144-155. Elsevier Ltd.
European Journal of Cancer, 158, pp. 144-155
PLCRC study group 2021, ' Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer : A population-based study ', European Journal of Cancer, vol. 158, pp. 144-155 . https://doi.org/10.1016/j.ejca.2021.08.050
European Journal of Cancer, 158, 144-155
European Journal of Cancer, 158, 144-155. Pergamon
European Journal of Cancer, 158, 144-155. Elsevier Ltd.
European Journal of Cancer, 158, pp. 144-155
PLCRC study group 2021, ' Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer : A population-based study ', European Journal of Cancer, vol. 158, pp. 144-155 . https://doi.org/10.1016/j.ejca.2021.08.050
European Journal of Cancer, 158, 144-155
Background The aim of this nationwide cohort study was to examine the course of symptoms and trajectories of health-related quality of life (HR-QoL) and psychological distress during follow-up and to identify vulnerable patients. Methods Patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2f6e79edc9a5d65d0698ea0d020a5de
https://pure.amc.nl/en/publications/trajectories-of-healthrelated-quality-of-life-and-psychological-distress-in-patients-with-colorectal-cancer(0cca2467-3283-4075-9c77-4e6cefda0b77).html
https://pure.amc.nl/en/publications/trajectories-of-healthrelated-quality-of-life-and-psychological-distress-in-patients-with-colorectal-cancer(0cca2467-3283-4075-9c77-4e6cefda0b77).html
Autor:
Rhodé M Bijlsma, Stefan Sleijfer, Daan ten Bokkel Huinink, Emile E. Voest, Annelie Vulink, Annelien L. Bredenoord, Neeltje Steeghs, Theo van Voorthuizen, Els Witteveen, Martijn P. Lolkema, Joan B. Heijns, Margreet G. E. M. Ausems, Roel H. P. Wouters, Hester van Cruijsen, Laurens V. Beerepoot, Anne M. May, Hester Wessels
Publikováno v:
ESMO open, 5(2)
ESMO Open, 5(2):e000619. BMJ Publishing Group
ESMO Open
ESMO Open, 5(2):e000619. BMJ Publishing Group
ESMO Open
Background In precision medicine, somatic and germline DNA sequencing are essential to make genome-guided treatment decisions in patients with cancer. However, it can also uncover unsolicited findings (UFs) in germline DNA that could have a substanti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f027538db24b4c7c087b2ec614085b1e
https://dspace.library.uu.nl/handle/1874/396020
https://dspace.library.uu.nl/handle/1874/396020
Autor:
Remco de Bree, Hester van Cruijsen, Chris H.J. Terhaard, Annemieke Kok, Nicole M. de Roos, Marja J. Leermakers-Vermeer, Nina C. van der Linden
Publikováno v:
Nutrition in Clinical Practice, 32(2), 225-232
Nutrition in Clinical Practice, 32(2), 225. SAGE Publications Ltd
Nutrition in Clinical Practice 32 (2017) 2
Nutrition in Clinical Practice, 32(2), 225. SAGE Publications Ltd
Nutrition in Clinical Practice 32 (2017) 2
BACKGROUND: Chemoradiotherapy (CRT) is a major risk factor for malnutrition and dehydration in patients with head and neck cancer. Enteral support is often needed, and a percutaneous endoscopic gastrostomy (PEG) is frequently placed. Specific indicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a340f8d2b200d3b81e6ff588051118dc
https://research.wur.nl/en/publications/indicators-for-enteral-nutrition-use-and-prophylactic-percutaneou
https://research.wur.nl/en/publications/indicators-for-enteral-nutrition-use-and-prophylactic-percutaneou
Autor:
Cornelis J. A. Punt, Petronella O. Witteveen, Jane Robertson, Juliane M. Jürgensmeier, Hester van Cruijsen, Emile E. Voest, Thomas A. Puchalski, Martijn R. Meijerink, Giuseppe Giaccone, Klaas Hoekman, Owain Saunders, Carla M.L. van Herpen
Publikováno v:
van Cruijsen, H, Voest, E E, Punt, C J A, Hoekman, K, Witteveen, P O, Meijerink, M R, Puchalski, T A, Robertson, J, Saunders, O, Jurgensmeier, J M, van Herpen, C M L & Giaccone, G 2010, ' Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours ', European Journal of Cancer, vol. 46, no. 5, pp. 901-911 . https://doi.org/10.1016/j.ejca.2009.12.023
European journal of cancer (Oxford, England, 46(5), 901-911. Elsevier Limited
European Journal of Cancer, 46(5), 901-911. Pergamon
European Journal of Cancer, 46, 901-11
European Journal of Cancer, 46, 5, pp. 901-11
European journal of cancer (Oxford, England, 46(5), 901-911. Elsevier Limited
European Journal of Cancer, 46(5), 901-911. Pergamon
European Journal of Cancer, 46, 901-11
European Journal of Cancer, 46, 5, pp. 901-11
Contains fulltext : 89775.pdf (Publisher’s version ) (Closed access) AIM: Cediranib is a highly potent inhibitor of vascular endothelial growth factor receptor (VEGFR) signalling. Preclinical and clinical data suggest that inhibition of the VEGFR a
Autor:
Klaas Hoekman, Giuseppe Giaccone, Cors van Schaik, Radu A. Manoliu, Matthijs Kater, Jan Hein T.M. van Waesberghe, Martijn R. Meijerink, Hester van Cruijsen
Publikováno v:
European Radiology, 17(7), 1700-1713. Springer Verlag
Meijerink, M R, van Cruijsen, H, Hoekman, K, Kater, M, Schaik, C, van Waesberghe, J H T M, Giaccone, G & Manoliu, R A 2007, ' The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients ', European Radiology, vol. 17, no. 7, pp. 1700-1713 . https://doi.org/10.1007/s00330-006-0425-9
Meijerink, M R, van Cruijsen, H, Hoekman, K, Kater, M, Schaik, C, van Waesberghe, J H T M, Giaccone, G & Manoliu, R A 2007, ' The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients ', European Radiology, vol. 17, no. 7, pp. 1700-1713 . https://doi.org/10.1007/s00330-006-0425-9
The purpose of this study was to determine the feasibility of dynamic contrast-enhanced perfusion CT (CTP) in evaluating the hemodynamic response of tumors in the chest and abdomen treated with a combination of AZD2171 and gefitinib. Thirteen patient
Autor:
Hester van Cruijsen, Epie Boven, Laura Vroling, Yuana Yuana, Victor W.M. van Hinsbergh, Chad M. Gundy, Richard R. de Haas, Klaas Hoekman, Henk J. Broxterman, Gerrit Jan Schuurhuis
Publikováno v:
Thrombosis and Haemostasis, 98(2), 440-450. Schattauer GmbH
Vroling, L, Yuana, Y, Schuurhuis, G J, van Hinsbergh, V W M, Gundy, C, de Haas, R, van Cruijsen, H, Boven, E, Hoekman, K & Broxterman, H J 2007, ' VEGFR2 expressing circulating (progenitor) cell populations in volunteers and cancer patients ', Thrombosis and Haemostasis, vol. 98, no. 2, pp. 440-450 . https://doi.org/10.1160/TH07-03-0225
Vroling, L, Yuana, Y, Schuurhuis, G J, van Hinsbergh, V W M, Gundy, C, de Haas, R, van Cruijsen, H, Boven, E, Hoekman, K & Broxterman, H J 2007, ' VEGFR2 expressing circulating (progenitor) cell populations in volunteers and cancer patients ', Thrombosis and Haemostasis, vol. 98, no. 2, pp. 440-450 . https://doi.org/10.1160/TH07-03-0225
Circulating cells of several lineages are thought to participate in angiogenesis and tumor growth. Experimental studies in tumor-bearing mice have pointed to the potential importance of VEGF-responding circulating (endothelial) progenitor cells in tu